SIC
JAZZ icon

SJS Investment Consulting’s Jazz Pharmaceuticals JAZZ Stock Holding History

SJS Investment Consulting’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
840
+45
+6% +$9.86K 0.02% 165
2026
Q1 		$150K Buy
795
+38
+5% +$6.64K 0.02% 171
2025
Q4 		$129K Hold
757
– – 0.02% 176
2025
Q3 		$99.8K Hold
757
– – 0.01% 187
2025
Q2 		$80.3K Sell
757
-5
-0.7% -$543 0.01% 143
2025
Q1 		$94.6K Buy
762
+1
+0.1% +$130 0.02% 143
2024
Q4 		$93.7K Buy
761
+1
+0.1% +$118 0.02% 141
2024
Q3 		$84.7K Buy
760
+2
+0.3% +$219 0.01% 150
2024
Q2 		$80.9K Sell
758
-2
-0.3% -$220 0.02% 137
2024
Q1 		$91.5K Buy
760
+3
+0.4% +$367 0.02% 137
2023
Q4 		$93.1K Sell
757
-1
-0.1% -$125 0.02% 128
2023
Q3 		$98.1K Buy
758
+2
+0.3% +$266 0.02% 110
2023
Q2 		$93.7K Sell
756
-1
-0.1% -$135 0.02% 109
2023
Q1 		$111K Sell
757
-3
-0.4% -$444 0.03% 102
2022
Q4 		$121K Buy
760
+5
+0.7% +$733 0.04% 104
2022
Q3 		$101K Buy
+755
New +$115K 0.03% 117
2022
Q1 		$117K Buy
752
+2
+0.3% +$290 0.04% 124
2021
Q4 		$96K Buy
+750
New +$98.6K 0.03% 129

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

SJS Investment Consulting's JAZZ Position: Q2 2026 in Review

SJS Investment Consulting increased its Jazz Pharmaceuticals (JAZZ) stake by 5.7% in Q2 2026, buying an estimated $9.86K and bringing the position to 840 shares worth $202K. The position accounts for 0.02% of the portfolio, ranked #165.

SJS Investment Consulting first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • SJS Investment Consulting held 840 shares of Jazz Pharmaceuticals worth $202K as of Q2 2026.
  • SJS Investment Consulting bought 45 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.86K.
  • Jazz Pharmaceuticals made up 0.02% of SJS Investment Consulting's portfolio in Q2 2026, its #165 holding.
  • SJS Investment Consulting first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.